论文部分内容阅读
目的观察稳心颗粒联合酒石酸美托洛尔治疗冠心病室性早搏的临床疗效。方法对2015年4月—2016年4月接受冠心病室性早搏治疗的患者进行随机挑选,挑选200例患者进行随机分组治疗,分别为观察组和对照组,每组人数各为100例。在治疗期间,观察组给予联合治疗,即为稳心颗粒联合酒石酸美托洛尔治疗;对照组患者给予单纯的酒石酸美托洛尔。治疗后,观察两组患者的临床效果以及不良反应和复发情况等。结果观察组患者的总有效率为92.00%,对照组患者的总有效率为75%;观察组的临床疗效明显优于对照组,差异有统计学意义P<0.05;比较两组患者的不良反应,差异有统计学意义P<0.05;比较两组患者的复发情况,差异有统计学意义P<0.05。结论稳心颗粒联合酒石酸美托洛尔治疗冠心病室性早搏效果明显,可降低患者的不良反应以及复发情况,值得在临床上进行应用以及推广。
Objective To observe the clinical effect of Wenxin granule combined with metoprolol tartrate on premature ventricular contractions in patients with coronary heart disease. Methods From April 2015 to April 2016, patients undergoing premature ventricular contractions of coronary heart disease were randomly selected. 200 patients were randomly assigned to observation and control groups, with each of 100 patients in each group. During the treatment period, the observation group was treated with metoclopram in combination with Wenxin granule and Metoprolol in the control group. After treatment, observe the clinical effects of both groups of patients and adverse reactions and recurrence. Results The total effective rate was 92.00% in the observation group and 75% in the control group. The clinical efficacy of the observation group was significantly better than that of the control group, with a significant difference P <0.05. The adverse reactions of the two groups were compared , The difference was statistically significant P <0.05; Comparison of the recurrence between the two groups, the difference was statistically significant (P <0.05). Conclusion Wenxin granule combined with metoprolol tartrate has obvious curative effect on premature ventricular contractions in patients with coronary heart disease, which can reduce adverse reactions and recurrence of patients and is worthy of clinical application and promotion.